ALDX earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -3.72. Updated 2026-07-23.
Aldeyra The (ALDX) Research Hub
Aldeyra The (ALDX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.6417 USD (-1.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.72, market cap 0.10B. This hub links to the full technical, earnings and options research available for ALDX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.6417 USD (-1.23%) |
| 52-week range | 0.6035 USD – 2.53 USD |
| Trend regime | Range |
| 14-day RSI | 22.9 (Oversold) |
| Trailing P/E | -3.72 |
| Market cap | 0.10B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for ALDX
Covered Call on ALDX: how it works, illustrative setup around the real 0.6417 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ALDX: how it works, illustrative setup around the real 0.6417 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ALDX: how it works, illustrative setup around the real 0.6417 USD price, max profit/loss, breakeven and when to use it. Educational.
ALDX technical analysis: range, last 0.6417 USD, RSI 22.9, 52w range 0.6035 USD–2.53 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ALDX in?
Aldeyra The (ALDX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ALDX in an uptrend or downtrend?
As of 2026-10-26, ALDX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ALDX's trailing P/E ratio?
ALDX's trailing P/E is -3.72, with a market cap of 0.10B. See the earnings research page for full valuation detail.
When does ALDX next report earnings?
ALDX is next scheduled to report earnings on 2026-08-06.